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DPVAbstract Differential pulse voltammetry (DPV) has been used to develop an electro-analytical
procedure for the determination of ﬂutamide and evaluate its interaction with DNA immobilised
on the carbon paste electrode (CPE) surface. In 0.3 M phosphate buffer (pH 7.0 ± 0.01) as support-
ing electrolyte ﬂutamide produced a well deﬁned DPV peak at Ep = 0.75 V vs. SCE. The DPV
study on the DNA–ﬂutamide interaction clearly demonstrated that ﬂutamide interacts preferen-
tially with adenine and guanine groups in DNA. Thus, enabling to assign mechanism of action
of the anticancer drug, ﬂutamide. The developed method was successfully applied to the determina-
tion of ﬂutamide in pharmaceutical formulations. The work has been supplemented by UV spectral
study.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Study on the interaction between drugs and DNA (Oliveira
et al., 2009; Xiangqin et al., 2005; Maria et al., 1996; Raufa
et al., 2005) is very interesting and signiﬁcant not only in
understanding the mechanism of action of the drug, but also
for the design of new drugs (Xiaoquan et al., 2006). However,
mechanism of interactions between drug molecules and DNA
is still relatively little known. It is necessary to introduce more
simple methods for investigating the mechanism of drug–DNA
interaction. The understanding of the mechanism of interac-tion will promote designing of new DNA-targeted drugs.
The interaction of some anticancer drugs with DNA has been
studied with a variety of techniques (Ravikumar Naik and
Bhojya Naik, 2008) and in recent years there is a growing
interest in the electrochemical investigation of interaction be-
tween anticancer drugs and other DNA targeted molecules
and DNA (Yaheng et al., 2008; Nawaz et al., 2006; Kalanur
et al., 2009; Chu et al., 1998; Radi et al., 2003; Tiwari and
Pitre, 2008; Ye et al., 2005; Wang et al., 2006). DNA biosensor
technologies are currently under intense investigation (Raviku-
mar Naik and Bhojya Naik, 2008) owing to the great promise
for rapid and low cost detection of speciﬁc DNA sequences in
human viral and bacterial nucleic acids. A quantitative under-
standing of such factors that determine recognition of DNA
sites would be valuable in the rational design of new DNA
targeted molecules for application in chemotherapy and in
the development of roots for biotechnology based on DNA
hybridisation.
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Figure 2 Cyclic voltammogram of 100 ppm ﬂutamide in 0.3 M
phosphate buffer (pH 7.0 ± 0.01) at bare CPE, pulse amplitude
50 mV, scan rate 50 mVs1, current range 10 lA.
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Figure 1 Structure of ﬂutamide.
Voltammetric study of ds-DNA–ﬂutamide interaction at carbon paste electrode S1885Flutamide (4-nitro-3-triﬂuoromethylisobutylanilide) a syn-
thetic antiandrogenic compound with therapeutic use in pros-
tatic cancer has been electrochemically studied to propose a
new electroanalytical alternative for its quantitative determina-
tion in pharmaceutical forms. Flutamide is shown to be elec-
trochemically reducible in aqueous and mixed media, due to
the presence of the nitro aromatic moiety in the molecule.
The chemical structure of ﬂutamide is shown in Fig. 1.
Flutamide is used as antineoplastic and antiandrogen drug.
It is a powerful nonsteroidal androgen antagonist (Snycerski,
1989) which is used to treat prostate cancer and is believed
to block androgen receptor sites. This drug and its primary hy-
droxyl metabolite decrease the metabolism of C-19 steroids by
the cytochrome P-450 system at the target cells in the second-
ary sex organs.
In the present work we used DNA modiﬁed carbon paste
electrode in combination with differential pulse voltammetry
to obtain information about the interaction of ﬂutamide with
DNA. The work is mainly aimed to study the interaction of
ﬂutamide with DNA and to propose a suitable mechanism
of its interaction.
2. Experimental
2.1. Chemicals and apparatus
All reagents were of AR grade purchased commercially.
ds-DNA (Himedia Ltd., Mumbai) and ﬂutamide of Sigma
Aldrich were used. Solutions were prepared using deionised
double distilled water. Stock standard solution of ﬂutamide
was prepared in 90% ethanol.
The voltammetric studies were carried out in exploratory
mode on software connected XMetrohm 797 VA Computrace
(ion analyzer). The electrochemical cell consisted of a three
electrode assembly and a stirrer with carbon paste electrode
as a working electrode, a platinum wire as auxiliary electrode
and Aa/AgCl electrode as reference electrode. The nitrogen gas
was purged for 5 min. A systronics digital lpH meter model-
361 was used for pH measurements.
2.2. Preparation of carbon paste electrode
Carbon paste was prepared in usual way by hand-mixing
graphite powder and mineral oil. The ratio of graphite powder
to mineral oil was 70:30. The prepared paste was ﬁlled into the
Teﬂon well (Ravikumar Naik and Bhojya Naik, 2008). A Cop-
per wire ﬁxed to a graphite rod and inserted into the Teﬂon
well serves to establish electrical contact with the external cir-
cuit. A good reproducibility of electrode response was
achieved by simply renewing the surface of carbon paste elec-
trode. New electrode surface was formed by mechanically
pressing the carbon paste from the top of the Teﬂon wellsmoothening of the electrode surface was done by rolling a
smooth glass rod on the electrode surface and ﬁnally it was
cleaned carefully by distilled water. Each measurement in-
volved fresh carbon paste surface.
2.3. ds-DNA modiﬁed carbon paste electrode
The carbon paste electrode was pre-treated by applying a
potential of +1.70 V for 1 min in 0.3 M phosphate buffer.
ds-DNA was immobilised on pre-treated CPE (Tiwari and
Pitre 2008) by applying a potential of +0.50 V for 5 min in
0.1 mg/ml ds-DNA. The electrode was then rinsed with dis-
tilled water. The ds-DNA modiﬁed CPE was then immersed
into 0.3 M phosphate buffer (pH 7.0 ± 0.01) containing ﬂu-
tamide and differential pulse voltammogram was recorded.
3. Results and discussion
3.1. Electrochemical reduction of ﬂutamide at bare CPE
The electrochemical behaviour of ﬂutamide at CPE was inves-
tigated employing DPV and CV mode. The cyclic voltammo-
gram for the reduction of ﬂutamide (100 ppm) in 0.3 M
phosphate buffer (pH 7.0 ± 0.01) is shown in Fig. 2. In the
forward scan, one cathodic peak owing to the reduction of
the nitro group was observed and no peak was noticed in the
reverse scan suggesting that the reduction of ﬂutamide at
CPE is irreversible. Similar in case of DPV, when a solution
of ﬂutamide (100 ppm) in 0.3 M phosphate buffer of pH
7.0 ± 0.01, was electrolysed using bare CPE as working elec-
trode, it produced well deﬁned reduction peak at 0.75 V
due to reduction of NO2 group of ﬂutamide as shown in
Fig. 3. The linear relation between peak current and drug con-
centration was observed in the range of 20 ppm to 160 ppm
ﬂutamide. The differential pulse voltammograms of ﬂutamide
at different concentrations are shown in Fig. 4. Regression
data of the calibration line for quantitative determination of
ﬂutamide using differential pulse voltammetry are shown in
Table 1.
0 -200 -400 -600 -800 -1.00
Potential/ V vs. Ag/AgCl
0
-1.00
-2.00
-3.00
-4.00
-5.00
C
ur
re
nt
/ µ
A
 
sample
blank
Figure 3 Differential pulse voltammogram of 100 ppm ﬂutamide
in 0.3 M phosphate buffer (pH 7.0 ± 0.01) at bare CPE, pulse
amplitude 50 mV, scan rate 50 mVs1, current range 10 lA.
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Figure 4 Differential pulse voltammogram of different concen-
trations of ﬂutamide in 0.03 M phosphate buffer (pH 7.0 ± 0.01)
at bare CPE, pulse amplitude 50 mV (1:20 ppm, 2:40 ppm,
3:80 ppm, 4:100 ppm, 5:120 ppm, 6:140 ppm, 7:160 ppm).
Table 1 Regression data of the calibration line for quantita-
tive determination of ﬂutamide using differential pulse
voltammetry.
Parameters Diﬀerential pulse
voltammetry
Linearity range (ppm) 20–160
Slope (lA/ppm) 0.0416
Intercept (lA) 1.0153
Correlation coeﬃcient (r2) 0.977
Limit of detection (LOD) (ppm) 1.0
Limit of quantiﬁcation (LOQ) (ppm) 5.0
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Figure 5 Differential pulse voltammogram for 100 ppm ds-
DNA in 0.3 M phosphate buffer (pH 7.0 ± 0.01) at bare CPE,
pulse amplitude 50 mV, scan rate 50 mVs1, current range 10 lA.
S1886 P.K. Brahman et al.3.2. Electrochemical behaviour of ds-DNA at bare CPE
In 0.3 M phosphate buffer of pH 7.0 ± 0.01 the electrochem-
ical oxidation of ds-DNA involves a complex process whichoccurs at the speciﬁc groups adenine and guanine with differ-
ent electron transfer reaction rates. The differential pulse vol-
tammogram of 100 ppm ds-DNA at the pre-treated CPE gave
two anodic peaks (Liping et al., 2006) at +1.107 V and
+0.792 V corresponding to the oxidation of adenine and
guanine sites of ds-DNA respectively (Fig. 5). For both the
peaks the peak current was found to be proportional to ds-
DNA concentration.
3.3. Interaction of ﬂutamide with ds-DNA at bare CPE
After studying the electrochemical behaviour of ﬂutamide at
carbon paste electrode, we have been able to study its interac-
tion with ds-DNA. Experimental sets of solutions were pre-
pared by taking a ﬁxed concentration of ﬂutamide (100 ppm)
in 0.3 M Phosphate buffer of pH 7.0 ± 0.01 and varying the
conc. of ds-DNA from 20 to 60 ppm. The reduction of ﬂutam-
ide was investigated for each set. The ﬁrst set i.e. without ds-
DNA, produced a well deﬁned DPV reduction peak at
0.75 V which shifted to more electronegative potential with
increasing concentration of ds-DNA and peak current short-
ened. The decrease in peak current and shifting in peak poten-
tial may be explained on the bases of change of species
(Oliveira Brett, 1995; Kalanur et al., 2009; Tian et al., 2008)
that is reduced at CPE surface due to the formation of
drug–DNA complex.
In the differential pulse voltammetric study, the changes in
the peak current due to ﬂutamide reduction without and with
ds-DNA are shown in Fig. 6. The results show that peak cur-
rent due to ﬂutamide at bare electrode was higher (Kalanur
et al., 2009; Xia et al., 1998) than the peak current due to
the mixture of ﬂutamide–ds-DNA reduction at CPE. It was
observed that in recording the DP voltammogram of ﬂutamide
alone in forward scan a cathodic peak was observed, which
corresponds to the reduction of NO2 group of ﬂutamide. When
calf thymus ds-DNA was added to the solution of ﬂutamide, a
marked decrease in the peak current and shift of peak potential
to more negative value were observed.
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Figure 6 DPV curves of ﬂutamide at bare CPE in 0.3 M
phosphate buffer solution (pH 7.0 ± 0.01) curve – 1:80 ppm
ﬂutamide curve – 2:20 ppm ds-DNA curve – 3:40 ppm ds-DNA
curve – 4:60 ppm ds-DNA.
Voltammetric study of ds-DNA–ﬂutamide interaction at carbon paste electrode S18873.4. Interaction of ﬂutamide at ds-DNA modiﬁed CPE
The carbon paste electrode (2 mm diameter) was modiﬁed by
dipping it in a solution of 100 ppm ds-DNA solution and a po-
tential of +0.5 V was applied for 5 min. The electrode was
electrochemically conditioned by application of a DPV poten-
tial scan between 0 and +1.5 V in 0.3 M phosphate buffer. The
ds-DNA modiﬁed CPE was then placed in 0.3 M phosphate
buffer of pH 7.0 ± 0.01 containing 100 ppm ﬂutamide and
voltammogram was recorded. The change in DPV peak cur-
rent of ﬂutamide with bare and ds-DNA modiﬁed CPE is
shown in Fig. 7. Flutamide produced a reduction peak at
Ep = 0.75 V with bare CPE, whereas using ds-DNA modi-
ﬁed CPE it produced a peak with Ep = 0.78 V. The peak
current with bare CPE is higher (Xia et al., 1998) than peak
current obtained with the ds-DNA modiﬁed CPE. This indi-
cated the pre-concentration of ﬂutamide at ds-DNA modiﬁed
CPE electrode, due to the ds-DNA–ﬂutamide interaction. The0 -200 -400 -600 -800 -1.00 -1.20
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Figure 7 Curve (1) differential pulse voltammogram of 100 ppm
ﬂutamide at bare CPE in 0.3 M phosphate buffer (pH 7.0 ± 0.01),
curve (2) DPV of ﬂutamide at ds-DNA modiﬁed CPE pulse
amplitude 50 mV, scan rate 50 mVs1, current range 10 lA.peak potential for ﬂutamide peak is more negative at ds-DNA
modiﬁed CPE than that at bare CPE, indicating the intercala-
tive attractions and stacking interactions of ﬂutamide between
the base pairs of DNA.
3.5. UV–VIS evolution of ﬂutamide–ds-DNA interaction
To determine whether ﬂutamide inﬂuences the ds-DNA con-
formation, the absorption spectra of ds-DNA in the absence
and presence of ﬂutamide were monitored. The absorption
spectra of 50 ppm ﬂutamide are shown in Fig. 8. The ﬁgure
clearly shows two absorption bands for ﬂutamide at 225 and
300 nm, respectively whereas ds-DNA produced one absorp-
tion band at 260 nm. However, on recording the absorption
spectrum of the mixture of ds-DNA–ﬂutamide, only one
absorption band at 260 nm was recorded, which ascribes to
the combination of ds-DNA and ﬂutamide. The results are
in excellent agreement with author’s observations using elec-
trochemical study.
3.6. Interaction mechanism of action of ﬂutamide with ds-DNA
Flutamide is a new nonsteroidal antiandrogen useful in the
treatment of prostatic carcinoma. When a potential of
0.75 V was applied, ﬂutamide was reduced at the DNA-mod-
iﬁed electrode. In this way ﬂutamide generates an anion, this
reactive anion may oxidise one of the neighbouring guanine
site of the ds-DNA. During this process, electron transfer from
guanine moiety to the nitro group of ﬂutamide without hydro-
gen abstraction is likely to be the predominant reaction leading
to the formation of the guanine cation. The cation will under-
go hydrolysis forming semiquinone. This semiquinone may un-
dergo further reduction to the fully reduced ﬂutamide.
3.7. Analysis of ﬂutamide in tablet
Flutamide tablet was obtained from local commercial source.
An accurately weighed portion of ﬁnely powdered tablet was
transferred to a 50 ml beaker containing 20 ml doubly distilled
water. The solution was ﬁltered and diluted to 50 ml and
0.5 ml of diluted sample was added to electrochemical cell con-0.1
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Fig. 8 UV spectra of (A) 30 lg/ml ds-DNA, (B) 30 lg/ml
ﬂutamide and (C) mixture of ds-DNA–ﬂutamide (30:30 lg/ml).
Table 2 Assay results of ﬂutamide tablet by DPV and mean
recoveries.
Sample Parameter Added (mg) Found (mg)
Cytomid tablet
(pharmaceutical
formulation)
Nil 0.452
Amount 0.420 0.871
%R 99.88
R.S.D 0.2
%R= percentage recovery.
R.S.D. = relative standard deviation.
S1888 P.K. Brahman et al.taining 10 ml phosphate buffer solution (pH 7.0 ± 0.01) and
the total volume of the test solution was made to 25 ml and dif-
ferential pulse voltammogram was recorded using CPE as
working electrode. The amount of ﬂutamide was determined
by means of the standard addition method. The results
obtained using developed method was found to be in good
agreement with that reported by its manufacturer for its ﬂu-
tamide content. The percentage recovery and standard devia-
tion of the observed analytical data indicate the accuracy
and repeatability of the proposed voltammetric method for ﬂu-
tamide determination (Table 2).
4. Conclusion
The study on the interaction between the anticancer drug ﬂu-
tamide and ds-DNA is very important in the development of
a new anticancer drug. This paper investigated the interaction
of ﬂutamide with ds-DNA by DP voltammetric and UV spec-
tral studies. The electrochemical behaviour of ﬂutamide at car-
bon paste electrode was established. The electrochemical
process is irreversible. This work has shown experimental evi-
dence of interaction of ﬂutamide with ds-DNA and may con-
tribute to the understanding of the mechanism of action of
ﬂutamide as anticancer drug. A simple, rapid and sensitiveDPV method is proposed for the determination of ﬂutamide
in pharmaceutical formulations.
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